Invasive mold infections in intensive care in hematological patients

Area of Science:

• Critical Care Medicine
• Hematology
• Mycology

Background:

• Invasive mold infections (IMIs) are a leading cause of death in hematological malignancy patients, especially those critically ill.
• Increased numbers of high-risk patients in intensive care units (ICUs) face challenges from invasive aspergillosis and other mold infections, leading to acute respiratory failure and sepsis.

Purpose of the Study:

• This review synthesizes current knowledge on IMIs in critically ill hematological patients.
• Focus areas include epidemiology, diagnostic challenges, and management strategies.

Main Methods:

• Review of current literature on invasive mold infections in critically ill hematological patients.
• Focus on epidemiology, diagnosis, and management.

Main Results:

• The spectrum of IMIs is broadening, with a rise in non-Aspergillus molds like Mucorales, Fusarium, Scedosporium, and Lomentospora.
• Diagnosis in the ICU is difficult due to nonspecific clinical/radiological signs and challenges in applying conventional criteria.
• Advances in imaging, fungal biomarkers, and molecular methods enhance early detection; new antifungal drugs expand treatment options.

Conclusions:

• IMIs are linked to high mortality in critically ill hematological patients.
• Early diagnosis, swift antifungal therapy, and multidisciplinary care are vital for better outcomes.
• Future research should prioritize ICU-specific diagnostics, risk stratification, and incorporating novel antifungal therapies.